Connecting you to the knowledge you need

A Mayo Clinic podcast hosted by Bobbi Pritt, M.D., sharing knowledge and advances in testing, laboratory science, and the people who make it all happen behind the scenes. 

Bobbi Pritt, M.D.

Follow along on Twitter/X: @ParasiteGal

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.
March 13, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss infectious disease activity around the nation.

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.
February 27, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI).
Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.
February 13, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, for a conversation about quality management.

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.
January 30, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends.

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.
January 21, 2025

Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.
Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.
January 16, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss Dr. Morice’s recent article in Becker’s Hospital Review, “Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025.
Benefits of Automation in the Laboratory: Erin Graf, Ph.D.
January 9, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Erin Graf, Ph.D., co-director of Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, to discuss benefits of automation in the laboratory.   
The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.
January 2, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss emerging concerns about H5N1 avian influenza.

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.
December 12, 2024

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the progress of artificial intelligence (AI) and what’s next in this space.
Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.
December 5, 2024

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the latest in infectious disease outbreaks.

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.
November 21, 2024

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss how labs can enhance patient access to improve health equity.
Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC
November 14, 2024

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, to discuss how family medical history can inform genetic testing strategies.

View MoreView Less